Improving vaccines coverage needs to address fake news and weak science behind allegations about vaccines causing autism and other diseases. Read the collaborative research paper in Frontiers in Immunology with a contribution of Marie Neunez, member of the I3h executive team. Link to the paper
The first I3h PhD fellowship was awarded to Ilaria Natali who will work under the supervision of Patrick Legros, professor at ECARES on the topic of “Regulation and mergers in the pharmaceutical industry”.
Emma Ouni, a participant to our 2018 TM Program, recently published a paper describing a draft map of the human ovarian proteome for tissue engineering and clinical applications. A nice tool for translational research ! Link to the paper. Emna Ouni is Bioengineer – PhD student at Université Catholique de Louvain.
In a note just published in The New England Journal of Medicine, Mathias Dewatripont and Michel Goldman call U.S. policymakers to urgently consider a ban on the practice of certain companies to provide free samples of prescription opioids.
The provision of free drug samples for promotional purposes is common in the United States. However, there is evidence that free samples often do not reach the intended patient population, reduce patients’ adherence to their treatment plans, and eventually increase health care costs. In the case of prescription opioids, free samples can lead to even more dramatic consequences. Opioids are potent stimulators of the reward system of the brain, so getting a free “taste” of these medications can precipitate compulsive and long-lasting seeking of substances that reproduce their effects.